Skip to main navigation Skip to main content
  • KSBMR

JBM : Journal of Bone Metabolism

OPEN ACCESS
ABOUT
BROWSE ARTICLES
EDITORIAL POLICIES
FOR CONTRIBUTORS

Page Path

2
results for

"Wnt"

Article category

Keywords

Publication year

Authors

"Wnt"

Original Articles

Transforming Growth Factor-β Signaling Inhibits the Osteogenic Differentiation of Mesenchymal Stem Cells via Activation of Wnt/β-Catenin Pathway
Mahsa Tahoori, Azita Parvaneh Tafreshi, Fatemeh Naghshnejad, Bahman Zeynali
J Bone Metab 2025;32(1):11-20.
Published online February 28, 2025
DOI: https://doi.org/10.11005/jbm.24.761
Background
Due to the contradictory and temporally variable effects of transforming growth factor-β (TGF-β) and the Wnt/β-catenin pathways on osteogenic differentiation in different stem cell types, we sought to examine the activity of these pathways as well as their interaction during the osteogenic differentiation of the osteo-induced adiposederived mesenchymal stem cells (AD-MSCs).
Methods
The osteo-induced AD-MSCs were treated with TGF-β1 (1 ng/mL) either alone or together with its antagonist SB- 431542 (10 μM) or that of the Wnt antagonist, inhibitor of Wnt production 2 (IWP2) (3 μM), every 3 days for 21 days. Cells were then analyzed for calcium deposit, bone matrix production, and the osteogenic markers gene expression.
Results
Our results showed firstly that, either of the pathways is active since the mRNA expressions of their respective target genes, PAI-1 and Cyclin D1 were detectable although the latter was at a very low level. Secondly that, treatment with TGF-β1 decreased levels of calcium deposit, bone matrix production and the osteogenic markers gene expression. Accordingly, osteogenesis was induced in those treated with SB either alone or together with the TGF-β1, pointing to inhibitory effect of TGF-β pathway on osteogenic differentiation. Thirdly that following treatment with IWP2 and TGF-β1, the inhibitory effect of TGF-β1 on bone matrix production was reversed. Fourthly, there was constantly low expression of Wnt3amRNA but progressively increasing that of its endogenous antagonist Dkk-1mRNA throughout.
Conclusions
Together these results suggest that TGF-β1 requires the active Wnt/β-catenin signaling pathway to exert its inhibitory effects on osteogenic differentiation of AD-MSCs.

Citations

Citations to this article as recorded by  Crossref logo
  • 1. Impact of primary cochlear implantation packing materials on reimplantation surgical difficulty and histopathological outcomes: a retrospective cohort study
    Yuanjun Liu, Jilei Zhang, Jie Cao, Lisheng Yu, Lin Han
    Acta Oto-Laryngologica.2026; 146(4): 478.     CrossRef
  • 2. Effects of Bone Morphogenetic Protein Agonist Small Molecule, SB4, on Osteogenic Differentiation of Adipose-Derived Mesenchymal Stem Cells
    Fatemeh Naghshnejad, Bahman Zeynali, Iman Shabani, Azita Parvaneh Tafreshi
    Journal of Bone Metabolism.2026; 33(1): 18.     CrossRef
  • 3. Knockdown of IER3 Promotes Osteogenic Differentiation of Human Mesenchymal Stem Cells
    Yuqing Han, Hongyang Ma, Zhihui Tang, Chanyuan Jin
    Biomedicines.2025; 13(4): 947.     CrossRef
  • 4. Gingival Stem Cell‐Conditioned Media and Low‐Level Laser Therapy Enhance Periodontal Ligament Stem Cells Function by Upregulating Wnt and TGF‐β Pathway Components: An In Vitro Study
    Mohammed Y. Aljabri, Yaser A. Alhazmi, Salah A. Elsayyad, Shehabeldin M. Saber, Mohamed Shamel
    Clinical and Experimental Dental Research.2025;[Epub]     CrossRef
  • 3,821 View
  • 71 Download
  • Crossref
Bone Marrow Adiposity, Bone Mineral Density and Wnt/β-catenin Pathway Inhibitors Levels in Hemodialysis Patients
Yue-Pei Wang, Nada Khelifi, Cyrille de Halleux, Roth-Visal Ung, France Samson, Claudia Gagnon, Fabrice Mac-Way
J Bone Metab 2022;29(2):113-122.
Published online May 31, 2022
DOI: https://doi.org/10.11005/jbm.2022.29.2.113
Background
Marrow adipose tissue (MAT) is known to accumulate in patients with chronic kidney disease. This pilot study aimed to evaluate bone mineral density (BMD), MAT, visceral adipose tissue (VAT), and subcutaneous adipose tissue (SAT) using computed tomography (CT) scans and to explore correlations between bone parameters, circulating Wnt/β-catenin pathway inhibitor levels, and adipose tissue parameters.
Methods
Single-center cross-sectional pilot study conducted in hemodialysis patients at the Centre Universitaire de Québec, Hôtel-Dieu de Québec hospital, Canada. CT-scan slices were acquired at the levels of the hip, L3 vertebra, and tibia. Volumetric and areal BMD, tibia cortical thickness, VAT and SAT area, and fat marrow index (FMI) were analyzed using the Mindways QCT Pro software. Blood levels of sclerostin, dickkopf-related protein 1 (DKK1), fibroblast growth factor 23, and α-Klotho were assessed. Spearman’s rho test was used to evaluate correlations.
Results
Fifteen hemodialysis patients (median age, 75 [66–82] years; 80% male; dialysis vintage, 39.3 [27.4–71.0] months) were included. While inverse correlations were obtained between L3 FMI and BMD, positive correlations were found between proximal tibial FMI and vertebral and tibial BMD, as well as with tibial (proximal and distal) cortical thickness. VAT had a positive correlation with α-Klotho levels, whereas L3 FMI had a negative correlation with DKK1 levels.
Conclusions
CT-scan allows simultaneous evaluation of bone and marrow adiposity in dialysis patients. Correlations between MAT and BMD vary depending on the bone site evaluated. DKK1 and α-Klotho levels correlate with adipose tissue accumulation in dialysis patients.

Citations

Citations to this article as recorded by  Crossref logo
  • 1. Site-specific inverse associations between FGF23 levels and marrow adiposity content at the proximal femur in post-menopausal women
    Julien Paccou, Sammy Badr, Nassima Ramdane, Laetitia Michou, Guillaume Courbon, Romuald Mentaverri
    Bone.2026; 205: 117813.     CrossRef
  • 2. Comparison of Differences in Cell Migration during the Osteogenic and Adipogenic Differentiation of the Bone Marrow-Derived Stem Cells
    Anirban Sardar, Shikha Verma, Anuj Raj, Bhaskar Maji, Ritu Trivedi
    Journal of Bone Metabolism.2025; 32(2): 69.     CrossRef
  • 3. Association of serum sclerostin levels with marrow adiposity in postmenopausal women with glucocorticoid-induced osteoporosis
    Wei Li, Wei Wang, Minlan Zhang, Qi Chen, Fengyi Li, Shaojun Li
    BMC Endocrine Disorders.2024;[Epub]     CrossRef
  • 4. Relationships between Circulating Sclerostin, Bone Marrow Adiposity, Other Adipose Deposits and Lean Mass in Post-Menopausal Women
    Marion Courtalin, Nicolas Bertheaume, Sammy Badr, Alexandrine During, Daniela Lombardo, Valérie Deken, Bernard Cortet, Aline Clabaut, Julien Paccou
    International Journal of Molecular Sciences.2023; 24(6): 5922.     CrossRef
  • 5. Relationship between bone marrow adipose tissue and kidney function in postmenopausal women
    Sammy Badr, Anne Cotten, Romuald Mentaverri, Daniela Lombardo, Julien Labreuche, Claire Martin, Lucie Hénaut, Bernard Cortet, Julien Paccou
    Bone Reports.2023; 19: 101713.     CrossRef
  • 7,369 View
  • 76 Download
  • Crossref